Omnia SanaPlant Comparison
Ginko vs Panax Ginseng
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Ginko and Panax Ginseng: they share 6 indicated uses (arthritis / joint pain, cardiovascular / heart health, cognitive function, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Ginko | Panax Ginseng | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Cardiovascular / heart health | 5/10 | 5/10 | Comparable evidence |
| Cognitive function | 6/10 | 9/10 | Stronger for Panax Ginseng |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Panax Ginseng |
| Memory | 6/10 | 8/10 | Stronger for Panax Ginseng |
| Skin irritation | 1/10 | 5/10 | Stronger for Panax Ginseng |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Antioxidant flavonoids of the leaf, standardised in clinical extracts.
Unique diterpene and sesquiterpene lactones responsible for platelet-activating-factor antagonism and much of the neuroprotective and circulatory activity; also the basis of the bleeding-risk caution.
A neurotoxic compound present in the raw seed; the reason only cooked seed in small amounts, or standardised leaf extract, is used medicinally.
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally well tolerated at standard doses but notable interactions exist. Ginkgo has antiplatelet and anticoagulant effects and should not be combined with warfarin, aspirin, or other blood-thinning medications without medical supervision. May lower the seizure threshold — avoid in epilepsy. Possible side effects include headache, dizziness, and GI upset. The raw seeds contain ginkgotoxin and are toxic; only processed leaf extracts are used medicinally.
Duke (2002) rates ginkgo as + (downgraded from higher rating for safety concerns) while noting clinical evidence (score 2) for anti-aggregant (platelet-inhibitory), anti-Alzheimer, and antioxidant activities. Commission E approves ginkgo leaf extract for cognitive deficits, peripheral circulatory disorders, and vertigo. However, Duke emphasizes significant safety concerns: ginkgo substantially increases bleeding risk when combined with anticoagulants (warfarin, aspirin, NSAIDs) and may cause spontaneous bleeding at high doses alone. Dose: 120–240 mg standardized extract (EGb 761) daily. Contraindicated with anticoagulants without medical supervision (Duke, 2002).
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
External Ids
Botanical Description
Ancient deciduous tree, a 'living fossil' with no close living relatives, bearing distinctive fan-shaped leaves with parallel forking veins that turn brilliant gold in autumn. The tree is dioecious (separate male and female trees); female trees bear fleshy, foul-smelling seed coats surrounding an edible inner nut (ginkgo nut) once the outer flesh is removed.[2]
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Habitat
Native to China, where a small number of wild populations survive; now cultivated worldwide as a resilient, pollution-tolerant ornamental and medicinal tree.
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Harvesting
Leaves are picked in late summer to autumn, when flavonoid and terpenoid content is highest, and processed into standardised extracts; the inner seed is collected in autumn from fallen fruit, with the malodorous outer flesh removed (handled with gloves, as it can irritate skin).
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Traditional Uses
Ginkgo leaf and seed have a long East Asian tradition: the seed used in traditional Chinese medicine (in small, cooked amounts) for respiratory complaints, and the leaf, though a more recent addition to Western herbalism, now one of the most extensively studied botanicals for cognitive and peripheral circulatory support, reflecting decades of standardised-extract clinical research.[2]
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Preparations
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
Clinical trials for cognitive and circulatory support commonly use around 120-240 mg of standardised leaf extract daily, in divided doses. Educational reference only, not a prescription.
References
Drug Class Interactions
Pairings
Ginkgo and garlic both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[16, 19]
Ginkgo and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginkgo and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
Ginkgo and ginseng both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19]
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
Lookalikes Review
References & Sources
- Tan, M.S., Yu, J.T., Tan, C.C., Wang, H.F. et al (2015) 'Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis', Journal of Alzheimer's Disease, 43(2), pp. 589-603. doi:10.3233/JAD-140837 Meta-analysis / review
https://doi.org/10.3233/JAD-140837 - Singh, S.K., Srivastav, S., Castellani, R.J., Plascencia-Villa, G. and Perry, G (2019) 'Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders', Neurotherapeutics, 16(3), pp. 666-674. doi:10.1007/s13311-019-00767-8 Traditional / reference
https://doi.org/10.1007/s13311-019-00767-8 - Diamond, B.J. and Bailey, M.R (2013) 'Ginkgo biloba: indications, mechanisms, and safety', Psychiatric Clinics of North America, 36(1), pp. 73-83. doi:10.1016/j.psc.2012.12.006 Traditional / reference
https://doi.org/10.1016/j.psc.2012.12.006 - DeKosky, S.T., Williamson, J.D., Fitzpatrick, A.L. et al (2008) 'Ginkgo biloba for prevention of dementia: a randomized controlled trial', 300(19), pp. 2253--2262. doi:10.1001/jama.2008.683 Randomized trial
https://doi.org/10.1001/jama.2008.683 - Zhu, C., Liu, J., Lin, J., Xu, J. and Yu, E (2024) 'Investigating the effects of Ginkgo biloba leaf extract on cognitive function in Alzheimer's disease', CNS Neuroscience & Therapeutics, 30(9), pp. e14914. doi:10.1111/cns.14914 Preclinical
https://doi.org/10.1111/cns.14914 - Diamond, B.J., Shiflett, S.C., Feiwel, N., Matheis, R.J., Noskin, O., Richards, J.A. and Schoenberger, N.E (2000) 'Ginkgo biloba extract: mechanisms and clinical indications', Archives of Physical Medicine and Rehabilitation, 81(5), pp. 668-678. doi:10.1016/s0003-9993(00)90052-2 Meta-analysis / review
https://doi.org/10.1016/s0003-9993(00)90052-2 - Dubey, A.K., Shankar, P.R., Upadhyaya, D. and Deshpande, V.Y (2004) 'Ginkgo biloba--an appraisal', Kathmandu University Medical Journal, 2(3), pp. 225-229. Meta-analysis / review
https://scholar.google.com/scholar?q=Ginkgo%20biloba--an%20appraisal - Christen, Y (2004) 'Ginkgo biloba and neurodegenerative disorders', Frontiers in Bioscience, 9, pp. 3091-3104. doi:10.2741/1462 Meta-analysis / review
https://doi.org/10.2741/1462 - Sereda, M., Xia, J., Scutt, P., Hilton, M.P., El Refaie, A. and Hoare, D.J (2022) 'Ginkgo biloba for tinnitus', Cochrane Database of Systematic Reviews, 11, pp. CD013514. doi:10.1002/14651858.CD013514.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD013514.pub2 - DeFeudis, F.V. and Drieu, K (2000) 'Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications', Current Drug Targets, 1(1), pp. 25-58. doi:10.2174/1389450003349380 Meta-analysis / review
https://doi.org/10.2174/1389450003349380 - Xie, L., Zhu, Q. and Lu, J (2022) 'Can we use Ginkgo biloba extract to treat Alzheimer's disease? Lessons from preclinical and clinical studies', Cells, 11(3), pp. 479. doi:10.3390/cells11030479 Meta-analysis / review
https://doi.org/10.3390/cells11030479 - von Gunten, A., Schlaefke, S. and Uberla, K (2015) 'Efficacy of Ginkgo biloba extract EGb 761 in dementia with behavioural and psychological symptoms: a systematic review', World Journal of Biological Psychiatry, 17(8), pp. 622-633. doi:10.3109/15622975.2015.1066513 Meta-analysis / review
https://doi.org/10.3109/15622975.2015.1066513 - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Kanowski, S., Herrmann, W.M., Stephan, K., Wierich, W. and Hörr, R (1996) 'Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia', 29(2), pp. 47--56. doi:10.1016/s0944-7113(97)80021-9 Randomized trial
https://doi.org/10.1016/s0944-7113(97)80021-9 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Bent, S., Goldberg, H., Padula, A. and Avins, A.L (2005) 'Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature', Journal of General Internal Medicine, 20(7), pp. 657-661. doi:10.1111/j.1525-1497.2005.0121.x Meta-analysis / review
https://doi.org/10.1111/j.1525-1497.2005.0121.x - Diamond, B.J. and Bailey, M.R (2013) 'Ginkgo biloba: indications, mechanisms, and safety', Psychiatric Clinics of North America, 36(1), pp. 73-83. doi:10.1016/j.psc.2012.12.006 Meta-analysis / review
https://doi.org/10.1016/j.psc.2012.12.006 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.